Share Price and Basic Stock Data
Last Updated: November 26, 2025, 6:19 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Thirumalai Chemicals Ltd operates in the specialty chemicals sector, with a current market capitalization of ₹2,979 Cr and a share price of ₹249. The company reported a total revenue of ₹2,132 Cr for the fiscal year ending March 2023, showing a modest increase from ₹2,083 Cr in March 2024 and a projected decline to ₹2,050 Cr in March 2025. Quarterly sales exhibited fluctuations, peaking at ₹621 Cr in June 2022 and dropping to ₹431 Cr by March 2023. However, sales showed signs of recovery, with ₹542 Cr recorded in September 2023 and ₹555 Cr expected in June 2024. Despite these fluctuations, the trailing twelve months (TTM) sales stood at ₹1,865 Cr, indicating a challenging environment for consistent revenue generation. This volatility may be attributed to market conditions and operational inefficiencies impacting Thirumalai’s performance compared to peers in the specialty chemicals sector.
Profitability and Efficiency Metrics
Thirumalai Chemicals reported a net profit of -₹149 Cr, reflecting ongoing challenges in profitability. The operating profit margin (OPM) stood at -6%, indicating that the company’s expenses consistently exceeded its revenues. The operating profit fluctuated significantly over the quarters, with a high of ₹97 Cr in June 2022 and a low of -₹27 Cr by June 2025. The interest coverage ratio (ICR) was recorded at 1.41x, suggesting that the company has a tight margin for covering interest obligations, posing a risk to financial stability. The return on equity (ROE) measured at 4.13% is notably low, while the return on capital employed (ROCE) was just 0.26%. These metrics indicate that Thirumalai Chemicals faces considerable efficiency challenges, struggling to translate revenues into profit relative to its capital base, which is lower than the typical sector benchmarks.
Balance Sheet Strength and Financial Ratios
The balance sheet of Thirumalai Chemicals reflects a total debt of ₹2,086 Cr against reserves of ₹1,521 Cr, highlighting a leveraged position with a debt-to-equity ratio of 1.48x. This level of debt raises concerns about financial flexibility, especially as the company reported a negative net profit and declining operating margins. The current ratio stood at 1.04x, suggesting that the company has just sufficient liquidity to cover short-term liabilities, but it is on the lower end of acceptable levels. The price-to-book value (P/BV) ratio of 2.15x indicates that the market values the company at a premium over its book value, which could suggest investor optimism or overvaluation. However, the declining trend in net profit and operating performance raises questions about the sustainability of this valuation in light of the company’s operational challenges.
Shareholding Pattern and Investor Confidence
Thirumalai Chemicals has a diverse shareholding structure, with promoters holding 36.13% of the equity, while institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 2.15% and 9.32%, respectively. The public holds a significant share of 52.39%, reflecting a broad base of retail investor participation. However, the promoter stake has seen a steady decline from 42.01% in December 2022 to the current level, which may indicate waning confidence from insiders. The number of shareholders has also decreased from 81,997 in December 2022 to 58,416 now, suggesting potential concerns among investors regarding the company’s performance and outlook. This declining investor confidence, coupled with the company’s financial challenges, may impact future capital raising efforts and overall market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Thirumalai Chemicals faces a challenging environment characterized by fluctuating sales and profitability issues. The company’s ongoing operational inefficiencies and high debt levels pose significant risks to its financial stability. The potential for recovery hinges on improvements in operational efficiency and cost management, as well as a favorable market environment for specialty chemicals. Should the company successfully address these issues, it may stabilize its financial performance and regain investor confidence. Conversely, continued underperformance could lead to further declines in market capitalization and shareholder sentiment. Ultimately, Thirumalai’s ability to navigate these challenges will determine its future trajectory in the competitive specialty chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Thirumalai Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 426 Cr. | 46.4 | 86.7/42.6 | 26.5 | 20.5 | 0.86 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 36.1 Cr. | 73.5 | 103/56.0 | 17.3 | 89.6 | 1.36 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.2 Cr. | 680 | 988/600 | 21.3 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,676 Cr. | 81.1 | 111/78.0 | 24.3 | 22.0 | 0.62 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 647 Cr. | 260 | 453/241 | 23.2 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,901.36 Cr | 736.42 | 63.11 | 183.02 | 0.42% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 621 | 572 | 508 | 431 | 523 | 542 | 492 | 527 | 555 | 525 | 447 | 523 | 450 |
| Expenses | 525 | 511 | 479 | 432 | 485 | 527 | 498 | 523 | 524 | 502 | 467 | 508 | 477 |
| Operating Profit | 97 | 61 | 29 | -1 | 38 | 15 | -6 | 4 | 31 | 24 | -20 | 15 | -27 |
| OPM % | 16% | 11% | 6% | -0% | 7% | 3% | -1% | 1% | 6% | 4% | -5% | 3% | -6% |
| Other Income | 3 | 6 | 11 | 11 | 5 | 6 | 4 | 4 | 3 | 9 | 0 | 8 | 2 |
| Interest | 6 | 7 | 11 | 7 | 10 | 10 | 12 | 10 | 9 | 10 | 14 | 15 | 18 |
| Depreciation | 13 | 13 | 14 | 16 | 16 | 16 | 15 | 17 | 14 | 13 | 16 | 18 | 22 |
| Profit before tax | 81 | 47 | 14 | -13 | 17 | -4 | -29 | -19 | 11 | 9 | -50 | -11 | -64 |
| Tax % | 26% | 27% | 41% | 0% | 37% | 47% | -20% | 10% | 53% | 47% | -16% | 28% | -7% |
| Net Profit | 60 | 34 | 8 | -13 | 11 | -6 | -23 | -20 | 5 | 5 | -42 | -14 | -60 |
| EPS in Rs | 5.86 | 3.35 | 0.81 | -1.25 | 1.04 | -0.59 | -2.24 | -2.00 | 0.50 | 0.48 | -4.10 | -1.37 | -5.86 |
Last Updated: August 20, 2025, 2:15 am
Below is a detailed analysis of the quarterly data for Thirumalai Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 450.00 Cr.. The value appears to be declining and may need further review. It has decreased from 523.00 Cr. (Mar 2025) to 450.00 Cr., marking a decrease of 73.00 Cr..
- For Expenses, as of Jun 2025, the value is 477.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 508.00 Cr. (Mar 2025) to 477.00 Cr., marking a decrease of 31.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to -27.00 Cr., marking a decrease of 42.00 Cr..
- For OPM %, as of Jun 2025, the value is -6.00%. The value appears to be declining and may need further review. It has decreased from 3.00% (Mar 2025) to -6.00%, marking a decrease of 9.00%.
- For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Jun 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 4.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -64.00 Cr.. The value appears to be declining and may need further review. It has decreased from -11.00 Cr. (Mar 2025) to -64.00 Cr., marking a decrease of 53.00 Cr..
- For Tax %, as of Jun 2025, the value is -7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to -7.00%, marking a decrease of 35.00%.
- For Net Profit, as of Jun 2025, the value is -60.00 Cr.. The value appears to be declining and may need further review. It has decreased from -14.00 Cr. (Mar 2025) to -60.00 Cr., marking a decrease of 46.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -5.86. The value appears to be declining and may need further review. It has decreased from -1.37 (Mar 2025) to -5.86, marking a decrease of 4.49.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:17 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,275 | 1,070 | 940 | 1,028 | 1,312 | 1,261 | 1,085 | 1,086 | 1,998 | 2,132 | 2,083 | 2,050 | 1,865 |
| Expenses | 1,192 | 1,032 | 842 | 871 | 1,022 | 1,055 | 1,007 | 865 | 1,557 | 1,946 | 2,032 | 2,001 | 1,901 |
| Operating Profit | 83 | 38 | 98 | 158 | 290 | 206 | 78 | 221 | 441 | 186 | 51 | 49 | -36 |
| OPM % | 7% | 4% | 10% | 15% | 22% | 16% | 7% | 20% | 22% | 9% | 2% | 2% | -2% |
| Other Income | 3 | 8 | 5 | 4 | 7 | 12 | 21 | 7 | 12 | 30 | 19 | 21 | 19 |
| Interest | 49 | 35 | 23 | 17 | 13 | 12 | 17 | 21 | 20 | 31 | 42 | 49 | 74 |
| Depreciation | 23 | 18 | 25 | 36 | 31 | 36 | 44 | 50 | 57 | 56 | 63 | 61 | 78 |
| Profit before tax | 15 | -7 | 55 | 109 | 253 | 169 | 38 | 157 | 375 | 129 | -35 | -41 | -169 |
| Tax % | 20% | 102% | 41% | 35% | 33% | 33% | 39% | 25% | 25% | 31% | 12% | 13% | |
| Net Profit | 12 | -14 | 32 | 71 | 170 | 114 | 23 | 118 | 281 | 90 | -39 | -46 | -149 |
| EPS in Rs | 1.16 | -1.34 | 3.14 | 6.90 | 16.64 | 11.09 | 2.26 | 11.49 | 27.47 | 8.77 | -3.79 | -4.50 | -14.14 |
| Dividend Payout % | 0% | -30% | 51% | 27% | 12% | 18% | 0% | 19% | 9% | 17% | -26% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -216.67% | 328.57% | 121.88% | 139.44% | -32.94% | -79.82% | 413.04% | 138.14% | -67.97% | -143.33% | -17.95% |
| Change in YoY Net Profit Growth (%) | 0.00% | 545.24% | -206.70% | 17.56% | -172.38% | -46.88% | 492.87% | -274.91% | -206.11% | -75.36% | 125.38% |
Thirumalai Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 1% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -151% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 36% |
| 3 Years: | 9% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 0% |
| Last Year: | -4% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: November 9, 2025, 3:07 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 12 |
| Reserves | 205 | 183 | 208 | 388 | 563 | 658 | 628 | 793 | 1,075 | 1,182 | 1,136 | 1,145 | 1,521 |
| Borrowings | 222 | 142 | 91 | 62 | 50 | 103 | 197 | 183 | 165 | 514 | 1,252 | 1,786 | 2,086 |
| Other Liabilities | 321 | 212 | 211 | 327 | 202 | 370 | 365 | 358 | 612 | 654 | 922 | 867 | 727 |
| Total Liabilities | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 | 4,345 |
| Fixed Assets | 230 | 243 | 256 | 317 | 310 | 383 | 550 | 513 | 596 | 671 | 712 | 1,251 | 1,281 |
| CWIP | 18 | 7 | 18 | 9 | 44 | 159 | 82 | 126 | 64 | 406 | 1,200 | 1,352 | 1,740 |
| Investments | 5 | 5 | 5 | 77 | 104 | 150 | 49 | 136 | 180 | 132 | 173 | 200 | 210 |
| Other Assets | 503 | 291 | 241 | 383 | 367 | 449 | 519 | 569 | 1,022 | 1,150 | 1,236 | 1,005 | 1,114 |
| Total Assets | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 | 4,345 |
Below is a detailed analysis of the balance sheet data for Thirumalai Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,521.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,145.00 Cr. (Mar 2025) to 1,521.00 Cr., marking an increase of 376.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,086.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,786.00 Cr. (Mar 2025) to 2,086.00 Cr., marking an increase of 300.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 727.00 Cr.. The value appears to be improving (decreasing). It has decreased from 867.00 Cr. (Mar 2025) to 727.00 Cr., marking a decrease of 140.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,345.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,808.00 Cr. (Mar 2025) to 4,345.00 Cr., marking an increase of 537.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,251.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 30.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,740.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,352.00 Cr. (Mar 2025) to 1,740.00 Cr., marking an increase of 388.00 Cr..
- For Investments, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,114.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,005.00 Cr. (Mar 2025) to 1,114.00 Cr., marking an increase of 109.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,345.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,808.00 Cr. (Mar 2025) to 4,345.00 Cr., marking an increase of 537.00 Cr..
However, the Borrowings (2,086.00 Cr.) are higher than the Reserves (1,521.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -139.00 | -104.00 | 7.00 | 96.00 | 240.00 | 103.00 | -119.00 | 38.00 | 276.00 | -328.00 | 50.00 | 48.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 52 | 50 | 49 | 33 | 33 | 30 | 29 | 29 | 17 | 32 | 35 |
| Inventory Days | 74 | 42 | 38 | 82 | 59 | 84 | 69 | 74 | 74 | 76 | 55 | 57 |
| Days Payable | 59 | 38 | 92 | 139 | 53 | 119 | 123 | 129 | 141 | 118 | 113 | 103 |
| Cash Conversion Cycle | 82 | 56 | -3 | -8 | 39 | -2 | -24 | -26 | -39 | -25 | -26 | -11 |
| Working Capital Days | 3 | -8 | -15 | -5 | 37 | 4 | -5 | -19 | -23 | -61 | -93 | -57 |
| ROCE % | 14% | 7% | 24% | 33% | 49% | 26% | 7% | 20% | 35% | 11% | 0% | 0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 65,760 | 0.23 | 1.44 | 65,760 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Diluted EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Cash EPS (Rs.) | 1.46 | 2.38 | 14.21 | 32.99 | 16.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Revenue From Operations / Share (Rs.) | 200.15 | 203.43 | 208.23 | 195.14 | 106.03 |
| PBDIT / Share (Rs.) | 6.78 | 6.87 | 21.13 | 44.18 | 22.22 |
| PBIT / Share (Rs.) | 0.81 | 0.69 | 15.69 | 38.65 | 17.39 |
| PBT / Share (Rs.) | -3.99 | -3.37 | 12.64 | 36.66 | 15.34 |
| Net Profit / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| NP After MI And SOA / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| PBDIT Margin (%) | 3.38 | 3.37 | 10.14 | 22.63 | 20.95 |
| PBIT Margin (%) | 0.40 | 0.34 | 7.53 | 19.80 | 16.39 |
| PBT Margin (%) | -1.99 | -1.65 | 6.06 | 18.78 | 14.47 |
| Net Profit Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| NP After MI And SOA Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| Return on Networth / Equity (%) | -3.98 | -3.38 | 7.53 | 25.91 | 14.65 |
| Return on Capital Employeed (%) | 0.28 | 0.31 | 10.74 | 30.29 | 17.08 |
| Return On Assets (%) | -1.21 | -1.16 | 3.80 | 15.10 | 8.76 |
| Long Term Debt / Equity (X) | 1.21 | 0.70 | 0.12 | 0.12 | 0.19 |
| Total Debt / Equity (X) | 1.48 | 1.01 | 0.37 | 0.14 | 0.19 |
| Asset Turnover Ratio (%) | 0.57 | 0.73 | 1.01 | 1.02 | 0.73 |
| Current Ratio (X) | 1.04 | 1.10 | 1.22 | 1.86 | 1.90 |
| Quick Ratio (X) | 0.77 | 0.85 | 0.84 | 1.42 | 1.47 |
| Inventory Turnover Ratio (X) | 6.23 | 5.86 | 5.40 | 5.68 | 3.91 |
| Dividend Payout Ratio (NP) (%) | -22.21 | -39.59 | 28.49 | 8.01 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 68.26 | 62.92 | 17.59 | 6.66 | 0.00 |
| Earning Retention Ratio (%) | 122.21 | 139.59 | 71.51 | 91.99 | 0.00 |
| Cash Earning Retention Ratio (%) | 31.74 | 37.08 | 82.41 | 93.34 | 0.00 |
| Interest Coverage Ratio (X) | 1.41 | 1.69 | 6.92 | 22.21 | 10.88 |
| Interest Coverage Ratio (Post Tax) (X) | 0.06 | 0.07 | 3.87 | 14.81 | 6.63 |
| Enterprise Value (Cr.) | 3836.01 | 2961.10 | 1656.34 | 2334.91 | 725.01 |
| EV / Net Operating Revenue (X) | 1.87 | 1.42 | 0.77 | 1.17 | 0.66 |
| EV / EBITDA (X) | 55.27 | 42.09 | 7.66 | 5.16 | 3.19 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| Retention Ratios (%) | 122.21 | 139.59 | 71.50 | 91.98 | 0.00 |
| Price / BV (X) | 2.15 | 2.09 | 1.48 | 2.51 | 1.09 |
| Price / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| EarningsYield | -0.01 | -0.01 | 0.05 | 0.10 | 0.13 |
After reviewing the key financial ratios for Thirumalai Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Diluted EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 1.46, marking a decrease of 0.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 200.15. It has decreased from 203.43 (Mar 24) to 200.15, marking a decrease of 3.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.78. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.78, marking a decrease of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.81. This value is within the healthy range. It has increased from 0.69 (Mar 24) to 0.81, marking an increase of 0.12.
- For PBT / Share (Rs.), as of Mar 25, the value is -3.99. This value is below the healthy minimum of 0. It has decreased from -3.37 (Mar 24) to -3.99, marking a decrease of 0.62.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For PBDIT Margin (%), as of Mar 25, the value is 3.38. This value is below the healthy minimum of 10. It has increased from 3.37 (Mar 24) to 3.38, marking an increase of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 10. It has increased from 0.34 (Mar 24) to 0.40, marking an increase of 0.06.
- For PBT Margin (%), as of Mar 25, the value is -1.99. This value is below the healthy minimum of 10. It has decreased from -1.65 (Mar 24) to -1.99, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 5. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 8. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is -3.98. This value is below the healthy minimum of 15. It has decreased from -3.38 (Mar 24) to -3.98, marking a decrease of 0.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 10. It has decreased from 0.31 (Mar 24) to 0.28, marking a decrease of 0.03.
- For Return On Assets (%), as of Mar 25, the value is -1.21. This value is below the healthy minimum of 5. It has decreased from -1.16 (Mar 24) to -1.21, marking a decrease of 0.05.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.21. This value exceeds the healthy maximum of 1. It has increased from 0.70 (Mar 24) to 1.21, marking an increase of 0.51.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.48. This value exceeds the healthy maximum of 1. It has increased from 1.01 (Mar 24) to 1.48, marking an increase of 0.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.73 (Mar 24) to 0.57, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 1.5. It has decreased from 1.10 (Mar 24) to 1.04, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.77, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.23. This value is within the healthy range. It has increased from 5.86 (Mar 24) to 6.23, marking an increase of 0.37.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -22.21. This value is below the healthy minimum of 20. It has increased from -39.59 (Mar 24) to -22.21, marking an increase of 17.38.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 68.26. This value exceeds the healthy maximum of 50. It has increased from 62.92 (Mar 24) to 68.26, marking an increase of 5.34.
- For Earning Retention Ratio (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 31.74. This value is below the healthy minimum of 40. It has decreased from 37.08 (Mar 24) to 31.74, marking a decrease of 5.34.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 3. It has decreased from 1.69 (Mar 24) to 1.41, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 3. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,836.01. It has increased from 2,961.10 (Mar 24) to 3,836.01, marking an increase of 874.91.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.87, marking an increase of 0.45.
- For EV / EBITDA (X), as of Mar 25, the value is 55.27. This value exceeds the healthy maximum of 15. It has increased from 42.09 (Mar 24) to 55.27, marking an increase of 13.18.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For Retention Ratios (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Price / BV (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 2.15, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Thirumalai Chemicals Ltd:
- Net Profit Margin: -2.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.28% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -3.98% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.06
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.77
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 63.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -2.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Thirumalai House, Mumbai Maharashtra 400022 | Info@thirumalaichemicals.com http://www.thirumalaichemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R Parthasarathy | Chairman & Managing Director |
| Mrs. Ramya Bharathram | Managing Director & CFO |
| Mr. P Mohana Chandran Nair | Director |
| Mr. Arun Alagappan | Director |
| Mrs. Bhama Krishnamurthy | Director |
| Mr. Arun Ramanathan | Director |
| Mr. R Sampath | Director |
| Mr. Rajeev M Pandia | Director |
| Mr. M Somasundaram | Director |
FAQ
What is the intrinsic value of Thirumalai Chemicals Ltd?
Thirumalai Chemicals Ltd's intrinsic value (as of 27 November 2025) is 65.21 which is 72.94% lower the current market price of 241.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,852 Cr. market cap, FY2025-2026 high/low of 395/201, reserves of ₹1,521 Cr, and liabilities of 4,345 Cr.
What is the Market Cap of Thirumalai Chemicals Ltd?
The Market Cap of Thirumalai Chemicals Ltd is 2,852 Cr..
What is the current Stock Price of Thirumalai Chemicals Ltd as on 27 November 2025?
The current stock price of Thirumalai Chemicals Ltd as on 27 November 2025 is 241.
What is the High / Low of Thirumalai Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Thirumalai Chemicals Ltd stocks is 395/201.
What is the Stock P/E of Thirumalai Chemicals Ltd?
The Stock P/E of Thirumalai Chemicals Ltd is .
What is the Book Value of Thirumalai Chemicals Ltd?
The Book Value of Thirumalai Chemicals Ltd is 129.
What is the Dividend Yield of Thirumalai Chemicals Ltd?
The Dividend Yield of Thirumalai Chemicals Ltd is 0.00 %.
What is the ROCE of Thirumalai Chemicals Ltd?
The ROCE of Thirumalai Chemicals Ltd is 0.26 %.
What is the ROE of Thirumalai Chemicals Ltd?
The ROE of Thirumalai Chemicals Ltd is 4.13 %.
What is the Face Value of Thirumalai Chemicals Ltd?
The Face Value of Thirumalai Chemicals Ltd is 1.00.